|
Volumn 69, Issue 6, 1992, Pages 1513-1517
|
Plasmacytoma. Treatment results and conversion to myeloma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADULT;
AGED;
CANCER ADJUVANT THERAPY;
CANCER LOCALIZATION;
CANCER SIZE;
CANCER SURVIVAL;
CLINICAL ARTICLE;
COMPARATIVE STUDY;
DISEASE CLASSIFICATION;
FEMALE;
HUMAN;
HUMAN TISSUE;
MALE;
MALIGNANT TRANSFORMATION;
MONOCLONAL IMMUNOGLOBULINEMIA;
MYELOMA;
PLASMACYTOMA;
PRIORITY JOURNAL;
PROGNOSIS;
PROTEIN BLOOD LEVEL;
REVIEW;
SURVIVAL TIME;
ADULT;
AGED;
AGED, 80 AND OVER;
BONE MARROW;
BONE NEOPLASMS;
CELL TRANSFORMATION, NEOPLASTIC;
CHEMOTHERAPY, ADJUVANT;
COMBINED MODALITY THERAPY;
FEMALE;
FOLLOW-UP STUDIES;
HUMAN;
MALE;
MIDDLE AGE;
MULTIPLE MYELOMA;
NEOPLASMS, SECOND PRIMARY;
PLASMACYTOMA;
RADIOTHERAPY DOSAGE;
REMISSION INDUCTION;
RETROSPECTIVE STUDIES;
TREATMENT OUTCOME;
|
EID: 0026565682
PISSN: 0008543X
EISSN: 10970142
Source Type: Journal
DOI: 10.1002/1097-0142(19920315)69:6<1513::AID-CNCR2820690633>3.0.CO;2-X Document Type: Article |
Times cited : (290)
|
References (24)
|